Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Nimodipine Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Nimodipine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Capsule
      • 1.3.3 Solution
      • 1.3.4 Tablets
    • 1.4 Market Segment by Application
      • 1.4.1 Global Nimodipine Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
      • 1.4.4 Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Nimodipine Market Size
      • 2.1.1 Global Nimodipine Revenue 2014-2025
      • 2.1.2 Global Nimodipine Sales 2014-2025
    • 2.2 Nimodipine Growth Rate by Regions
      • 2.2.1 Global Nimodipine Sales by Regions 2014-2019
      • 2.2.2 Global Nimodipine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Nimodipine Sales by Manufacturers
      • 3.1.1 Nimodipine Sales by Manufacturers 2014-2019
      • 3.1.2 Nimodipine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Nimodipine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nimodipine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Nimodipine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Nimodipine Price by Manufacturers
    • 3.4 Key Manufacturers Nimodipine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Nimodipine Market
    • 3.6 Key Manufacturers Nimodipine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Capsule Sales and Revenue (2014-2019)
      • 4.1.2 Solution Sales and Revenue (2014-2019)
      • 4.1.3 Tablets Sales and Revenue (2014-2019)
    • 4.2 Global Nimodipine Sales Market Share by Type
    • 4.3 Global Nimodipine Revenue Market Share by Type
    • 4.4 Nimodipine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Nimodipine Sales by Application

    6 United States

    • 6.1 United States Nimodipine Breakdown Data by Company
    • 6.2 United States Nimodipine Breakdown Data by Type
    • 6.3 United States Nimodipine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Nimodipine Breakdown Data by Company
    • 7.2 European Union Nimodipine Breakdown Data by Type
    • 7.3 European Union Nimodipine Breakdown Data by Application

    8 China

    • 8.1 China Nimodipine Breakdown Data by Company
    • 8.2 China Nimodipine Breakdown Data by Type
    • 8.3 China Nimodipine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Nimodipine Breakdown Data by Company
    • 9.2 Rest of World Nimodipine Breakdown Data by Type
    • 9.3 Rest of World Nimodipine Breakdown Data by Application
    • 9.4 Rest of World Nimodipine Breakdown Data by Countries
      • 9.4.1 Rest of World Nimodipine Sales by Countries
      • 9.4.2 Rest of World Nimodipine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Sun Pharm Inds
      • 10.1.1 Sun Pharm Inds Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Nimodipine
      • 10.1.4 Nimodipine Product Introduction
      • 10.1.5 Sun Pharm Inds Recent Development
    • 10.2 Heritage Pharms
      • 10.2.1 Heritage Pharms Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Nimodipine
      • 10.2.4 Nimodipine Product Introduction
      • 10.2.5 Heritage Pharms Recent Development
    • 10.3 Bionpharma
      • 10.3.1 Bionpharma Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Nimodipine
      • 10.3.4 Nimodipine Product Introduction
      • 10.3.5 Bionpharma Recent Development
    • 10.4 Arbor Pharms
      • 10.4.1 Arbor Pharms Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Nimodipine
      • 10.4.4 Nimodipine Product Introduction
      • 10.4.5 Arbor Pharms Recent Development
    • 10.5 Thepharmanetwork
      • 10.5.1 Thepharmanetwork Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Nimodipine
      • 10.5.4 Nimodipine Product Introduction
      • 10.5.5 Thepharmanetwork Recent Development
    • 10.6 Sofgen Pharms
      • 10.6.1 Sofgen Pharms Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Nimodipine
      • 10.6.4 Nimodipine Product Introduction
      • 10.6.5 Sofgen Pharms Recent Development
    • 10.7 Bayer Vital GmbH
      • 10.7.1 Bayer Vital GmbH Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Nimodipine
      • 10.7.4 Nimodipine Product Introduction
      • 10.7.5 Bayer Vital GmbH Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Nimodipine Sales Channels
      • 11.2.2 Nimodipine Distributors
    • 11.3 Nimodipine Customers

    12 Market Forecast

    • 12.1 Global Nimodipine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Nimodipine Sales Forecast by Type
    • 12.3 Global Nimodipine Sales Forecast by Application
    • 12.4 Nimodipine Forecast by Regions
      • 12.4.1 Global Nimodipine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Nimodipine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Nimodipine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nimodipine.

      This report studies the global market size of Nimodipine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Nimodipine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Sun Pharm Inds
      Heritage Pharms
      Bionpharma
      Arbor Pharms
      Thepharmanetwork
      Sofgen Pharms
      Bayer Vital GmbH
      ...

      Market Segment by Product Type
      Capsule
      Solution
      Tablets

      Market Segment by Application
      Hospital
      Pharmacy
      Clinics

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Nimodipine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Nimodipine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Nimodipine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now